Back to All Events

Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)

  • IQVIA Solutions Denmark A/S Denmark (map)

On Monday, January 9th, 2023, the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) will discuss an sBLA-125387, for aflibercept solution for intravitreal injection, submitted by Regeneron Pharmaceuticals for the treatment of retinopathy of prematurity.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/january-9-2023-dermatologic-and-ophthalmic-drugs-advisory-committee-meeting-01092023#event-information
Earlier Event: December 13
Cardiovascular and Renal Drugs Advisory Committee
Later Event: January 24
Antimicrobial Drugs Advisory Committee Meeting